Expression, purification, and characterization of a structurally disordered and functional C-terminal autoinhibitory domain (AID) of the 70 kDa 40S ribosomal protein S6 kinase-1 (S6K1)

被引:7
|
作者
Ragan, Timothy J. [1 ]
Ross, Duncan B. [1 ]
Keshwani, Malik M. [2 ]
Harris, Thomas K. [1 ]
机构
[1] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA
[2] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA
关键词
custom gene synthesis; intrinsic disorder; disordered proteins; autoinhibition; phosphoinositide-dependent protein kinase-1; PDK1; proteolysis inhibition; minimal media;
D O I
10.1016/j.pep.2007.09.014
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
S6K1 is a member of the AGC subfamily of serine-threonine protein kinases, whereby catalytic activation requires dual phosphorylation of critical residues in the conserved T-loop (T229) and hydrophobic motif (HM; T389) peptide regions of its catalytic kinase domain (residues 1-398). In addition to its kinase domain, S6K1 contains a C-terminal autoinhibitory domain (AID; residues 399-502), which prevents T-loop and HM phosphorylation; and autoinhibition is relieved on multi-site Ser-Thr phosphorylation of the AID (S411, S418, T421, and S424). Interestingly, 66 of the 104 C-terminal AID amino acid residues were computer predicted to exist in structurally disordered peptide regions, begetting interest as to how such dynamics could be coupled to autoregulation. To begin addressing this issue, we developed and optimized protocols for efficient AID expression and purification. Consistent with computer predictions, aberrant mobilities in both SDS-PAGE and size-exclusion chromatography, as well as low chemical shift dispersion in H-1-N-15 HSQC NMR spectra, indicated purified recombinant AID to be largely unfolded. Yet, trans-addition of purified AID effectively inhibited PDK1-catalyzed T-loop phosphorylation of a catalytic kinase domain construct of S6K1. Using an identical purification protocol, similar protein yields of a tetraphospho-mimic mutant AID(D2ED) construct were obtained; and this construct displayed only weak inhibition of PDK1-catalyzed T229 phosphorylation. Purification of the structurally 'disordered' and functional C-terminal AID and AID(D2ED) constructs will facilitate studies aimed to understand the role of conformational plasticity and protein phosphorylation in modulating autoregulatory domain-domain interactions. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 50 条
  • [21] Gene Amplification of Ribosomal Protein S6 Kinase-1 and-2 in Gastric Cancer
    Yoshida, Shuhei
    Matsumoto, Kazuko
    Arao, Tokuzo
    Taniguchi, Hirokazu
    Goto, Isao
    Hanafusa, Toshiaki
    Nishio, Kazuto
    Yamada, Yasuhide
    ANTICANCER RESEARCH, 2013, 33 (02) : 469 - 475
  • [22] p53 modulates the effect of ribosomal protein S6 kinase1 (S6K1) on cisplatin toxicity in chronic myeloid leukemia cells
    Xiao, Ling-Yi
    Kan, Wai-Ming
    PHARMACOLOGICAL RESEARCH, 2017, 119 : 443 - 462
  • [23] Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase
    Chrestensen, CA
    Sturgill, TW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) : 27733 - 27741
  • [24] p70 Ribosomal protein S6 kinase (Rps6kb1): an update
    Bahrami-B, Farnaz
    Ataie-Kachoie, Parvin
    Pourgholami, Mohammad H.
    Morris, David L.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (12) : 1019 - 1025
  • [25] p21Waf1/Cip1 Is a Novel Downstream Target of 40S Ribosomal S6 Kinase 2
    Basu, Alakananda
    Xuan, Zhenyu
    CANCERS, 2024, 16 (22)
  • [26] Evaluation of Pathogenicity and Structural Alterations for the Mutations Identified in the Conserved Region of the C-Terminal Kinase Domain of Human-Ribosomal S6 Kinase 1
    Chikhale, Vaishnvee
    Goswami, Nabajyoti
    Khan, Mudassar Ali
    Borah, Probodh
    Varma, Ashok K.
    ACS OMEGA, 2023, 8 (18): : 16273 - 16283
  • [27] Inhibition of p70 Ribosomal S6 Kinase (S6K1) Reduces Cortical Blood Flow in a Rat Model of Autism-Tuberous Sclerosis
    Chi, Oak Z.
    Liu, Xia
    Fortus, Harvey
    Werlen, Guy
    Jacinto, Estela
    Weiss, Harvey R.
    NEUROMOLECULAR MEDICINE, 2024, 26 (01)
  • [29] Specificity of action of bisindolylmaleimide protein kinase C inhibitors: do they inhibit the 70 kDa ribosomal S6 kinase in cardiac myocytes?
    Roberts, NA
    Marber, MS
    Avkiran, M
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (10) : 1923 - 1928
  • [30] Functional Basis and Biophysical Approaches to Characterize the C-Terminal Domain of Human—Ribosomal S6 Kinases-3
    Bhanu P. Jagilinki
    Rajan Kumar Choudhary
    Pankaj S. Thapa
    Nikhil Gadewal
    M. V. Hosur
    Satish Kumar
    Ashok K. Varma
    Cell Biochemistry and Biophysics, 2016, 74 : 317 - 325